 SHARE EXCHANGE AGREEMENT  

 **EXHIBIT 10.1**



SHARE EXCHANGE AGREEMENT



by and among



AXIOM HOLDINGS, INC.

a Nevada Corporation



and



CJC HOLDINGS, LTD.,

A Hong Kong corporation



and



THE SHAREHOLDERS OF CJC HOLDINGS, LTD.



Dated as of October 10, 2016 

 
--- 



 **TABLE OF CONTENTS**



|

|

**PAGE**

| 
---|---|---|--- 



|



|


 
ARTICLE I. REPRESENTATIONS, COVENANTS, AND WARRANTIES OF CJC AND THE CJC
SHAREHOLDERS

|

1

| 

Section 1.01

|

Incorporation.

|

2

| 

Section 1.02

|

Authorized Shares and Capital.

|

2

| 

Section 1.03

|

Title to CJC Shares.

|

2

| 

Section 1.04

|

Subsidiaries and Predecessor Corporations

|

2

| 

Section 1.05

|

Financial Statements.

|

3

| 

Section 1.06

|

Additional Information

|

3

| 

Section 1.07

|

Options or Warrants

|

4

| 

Section 1.08

|

Absence of Certain Changes or Events

|

4

| 

Section 1.09

|

Litigation and Proceedings

|

4

| 

Section 1.10

|

Contracts.

|

4

| 

Section 1.11

|

Compliance With Laws and Regulations

|

5

| 

Section 1.12

|

CJC Schedules

|

5

| 

Section 1.13

|

Valid Obligation

|

5

| 

Section 1.14

|

Investment Representations.

|

5

| 



|



|


 
ARTICLE II. REPRESENTATIONS, COVENANTS, AND WARRANTIES OF AXIOM

|

7

| 

Section 2.01

|

Organization

|

7

| 

Section 2.02

|

Capitalization

|

8

| 

Section 2.03

|

Subsidiaries and Predecessor Corporations

|

8

| 

Section 2.04

|

Information

|

8

| 

Section 2.05

|

Options or Warrants

|

8

| 

Section 2.06

|

Absence of Certain Changes or Events

|

8

| 

Section 2.07

|

Litigation and Proceedings

|

9

| 

Section 2.08

|

Contracts.

|

9

| 

Section 2.09

|

No Conflict With Other Instruments

|

10

| 

Section 2.10

|

Compliance With Laws and Regulations

|

10

| 

Section 2.11

|

Approval of Agreement

|

10

| 

Section 2.12

|

Material Transactions or Affiliations

|

10

| 

Section 2.13

|

Axiom Schedules

|

10

| 

Section 2.14

|

Bank Accounts; Power of Attorney

|

10

| 

Section 2.15

|

Valid Obligation.

|

10

| 

Section 2.16

|

SEC Filings

|

10

| 



|



|


 
ARTICLE III. SHARE EXCHANGE

|

11

| 

Section 3.01

|

The Exchange.

|

11

| 

Section 3.02

|

Closing

|

11

| 

Section 3.03

|

Closing Events

|

11

| 

Section 3.04

|

Termination

|

11

| 



|



|



|


 
ARTICLE IV.

|

SPECIAL COVENANTS

|

12

| 

Section 4.01

|

Access to Properties and Records

|

12

| 

Section 4.02

|

Delivery of Books and Records

|

12

| 

Section 4.03

|

Third Party Consents and Certificates

|

12

| 

Section 4.04

|

Axiom SEC Filings.

|

12

| 

Section 4.05

|

Designation of Directors.

|

12

| 

Section 4.06

|

Actions Prior to Closing.

|

12

| 

Section 4.07

|

Indemnification.

|

14

| 

 

--- 



ARTICLE V. CONDITIONS PRECEDENT TO OBLIGATIONS OF AXIOM

|

14

| 
---|---|--- 

Section 5.01

|

Accuracy of Representations and Performance of Covenants

|

14

| 

Section 5.02

|

Officer's Certificate

|

15

| 

Section 5.03

|

No Governmental Prohibition

|

15

| 

Section 5.04

|

Consents

|

15

| 

Section 5.05

|

Other Items.

|

15

| 

Section 5.06

|

Definition

|

16

| 



|



|


 
ARTICLE VI. CONDITIONS PRECEDENT TO OBLIGATIONS OF AXIOM

|

16

| 

Section 6.01

|

Accuracy of Representations and Performance of Covenants

|

16

| 

Section 6.02

|

Officer's Certificate

|

16

| 

Section 6.03

|

Good Standing

|

16

| 

Section 6.04

|

No Governmental Prohibition

|

16

| 

Section 6.05

|

Axiom Shares

|

16

| 

Section 6.06

|

Other Items.

|

17

| 

Section 6.07

|

Definition

|

17

| 



|



|


 
ARTICLE VII. MISCELLANEOUS

|

17

| 

Section 7.01

|

Brokers

|

17

| 

Section 7.02

|

Governing Law

|

17

| 

Section 7.03

|

Waiver of Jury Trial

|

17

| 

Section 7.04

|

Notices

|

18

| 

Section 7.05

|

Attorneys' Fees

|

18

| 

Section 7.06

|

Confidentiality

|

18

| 

Section 7.07

|

Public Announcements and Filings

|

19

| 

Section 7.08

|

Schedules; Knowledge

|

19

| 

Section 7.09

|

Third Party Beneficiaries

|

19

| 

Section 7.10

|

Expenses

|

19

| 

Section 7.11

|

Entire Agreement

|

19

| 

Section 7.12

|

Survival; Termination

|

19

| 

Section 7.13

|

Counterparts

|

19

| 

Section 7.14

|

Amendment or Waiver

|

19

| 

Section 7.15

|

Successors and Assigns

|

19

| 

Section 7.16

|

Headings and Severability

|

19

| 

Section 7.17

|

Interpretation

|

20

| 

Section 7.18

|

Usage

|

20

| 

Section 7.19

|

Specific Performance

|

20

| 

Section 7.20

|

Commercially Reasonable Best Efforts

|

20

| 

 

--- 



 _CJC Schedules*_



Schedule 1.01

|

Articles of Association 

---|--- 

Schedule 1.03

|

Ownership of CJC Shares by the CJC Shareholders 

Schedule 1.05

|

Financial Statements 

Schedule 1.06

|

Additional Information 

Schedule 1.08(c)

|

Options, Warrants or Other Rights 

Schedule 1.09

|

Litigation and Proceedings 

Schedule 1.10(a)

|

Material Contracts 

Schedule 1.10(c)

|

Employment Agreements, Etc. 



 _Axiom Schedules*_



Schedule 2.01

|

Certificate of Incorporation and Bylaws 

---|--- 

Schedule 2.05

|

Options, Warrants or Other Rights 

Schedule 2.07

|

Litigation and Proceedings 

Schedule 2.12

|

Material Transactions or Affiliations 

Schedule 2.14

|

Bank Accounts; Power of Attorney 



 _Additional Schedules*_



Schedule 3.01

|

Number of Shares of Axiom Common Stock to be Received by Each CJC Shareholder 

---|--- 

Schedule 7.01

|

Finders and Brokers 

_____________

* The CJC Schedules, the Axiom Schedules and the Additional Schedules have been exchanged among the parties hereto or will be provided to each of the respective parties hereto prior to the Closing Date (as hereinafter defined). 


 
--- 



SHARE EXCHANGE AGREEMENT



THIS SHARE EXCHANGE AGREEMENT (hereinafter referred to as this "Agreement") is
entered into as of this 10th day of October, 2016, by and between Axiom
Holdings, Inc., a Nevada corporation ("Axiom"), with offices at 11637
Orpington Street, Orlando, Florida 32817, CJC Holdings, Ltd., a Hong Kong
corporation (together with the Subsidiaries, as defined below, "CJC") with
offices at Room C, 15/F., Ritz Plaza, 122 Austin Road, Tsimshatsui, Kowloon,
H.K. and the shareholders of CJC set forth on the signature page to this
Agreement (the "CJC Shareholders"), upon the following premises:



 _Premises_



WHEREAS, Axiom is a publicly held corporation organized under the laws of the
State of Nevada;



WHEREAS, CJC is a privately-held company organized under the laws of Hong
Kong;



WHEREAS, the CJC Shareholders collectively own all of the issued and
outstanding shares of CJC representing a 100% interest in CJC;



WHEREAS, Axiom agrees to acquire 100% of the issued and outstanding shares of
CJC from the CJC Shareholders in exchange for the issuance of 200,000,000
shares of Axiom's Common Stock, par value $0.001 per share (the "Common
Stock"), which shall represent approximately 58.8% of the issued and
outstanding shares of Axiom's Common Stock after giving effect to the
cancellation of 200,000,000 shares of Common Stock currently issued and
outstanding as the transactions contemplated herein (the "Exchange") and on
the Closing Date (as defined below), the CJC Shareholders will become
shareholders of Axiom; and



WHEREAS, for Federal income tax purposes, it is intended that the Exchange
qualify as a reorganization under the provisions of Section 368(a) of the
Internal Revenue Code of 1986, as amended;



 _Agreement_



NOW THEREFORE, on the stated premises and for and in consideration of the
mutual covenants and agreements hereinafter set forth and the mutual benefits
to the parties to be derived herefrom, the receipt and sufficiency of which
are hereby acknowledged and agreed, and intending to be legally bound hereby,
it is hereby agreed as follows:



ARTICLE I.

REPRESENTATIONS, COVENANTS, AND WARRANTIES OF CJC AND THE CJC SHAREHOLDERS



Section 1.01 _Incorporation._ CJC is a company duly organized, validly
existing, and in good standing under the laws of Hong Kong and has the
corporate power and is duly authorized under all applicable laws, regulations,
ordinances, and orders of public authorities to carry on its business in all
material respects as it is now being conducted. Schedule 1.01 includes a
complete and correct copy of the Articles of Association of CJC as in effect
on the date hereof. The execution and delivery of this Agreement does not, and
the consummation of the transactions contemplated hereby will not, violate any
provision of CJC's Articles of Association. CJC and each of the CJC
Shareholders have taken all actions required by law, its Articles of
Association, or otherwise to authorize the execution and delivery of this
Agreement. CJC and each of the CJC Shareholders has full power, authority, and
legal capacity and has taken all action required by law, its Articles of
Association, and otherwise to consummate the transactions herein contemplated.


 

--- 
\- 1 - 



Section 1.02 _Authorized Shares and Capital._ The authorized capital stock of
CJC consists of 100 common shares, with no par value (the "CJC Shares") of
which 100 CJC Shares are issued and outstanding. The CJC Shareholders own all
of the issued and outstanding CJC Shares representing a 100% interest in CJC.
The issued and outstanding CJC Shares are validly issued, fully paid, and non-
assessable and not issued in violation of the preemptive or other rights of
any individual, firm, corporation, partnership, limited liability company,
trust, incorporated or unincorporated association, joint venture, joint stock
company, Governmental Authority or other entity of any kind, and shall include
any successor (by merger or otherwise) of such entity (each, a "Person"). No
Person has any pre-emptive rights or similar rights to purchase or receive any
CJC Shares or any other equity interests in CJC.



Section 1.03 _Title to CJC Shares._ Each CJC Shareholder is, and on the
Closing Date will be, the record and beneficial owner and holder of all of the
CJC Shares as set forth on Schedule 1.03, free and clear of all Liens (as
defined below), and none of such CJC Shares is subject to pre-emptive or
similar rights, either pursuant to any organizational document, Requirement of
Law (as defined below) or any contract. "Requirements of Law" means, as to any
Person, any law, treaty, rule, regulation, right, privilege, qualification,
license or franchise or determination of an arbitrator or a court or other
Governmental Authority (as defined below), in each case applicable or binding
upon such Person or any of its property or to which such Person or any of its
property is subject, or pertaining to any or all of the transactions
contemplated or referred to herein. "Lien" means any mortgage, deed of trust,
pledge, hypothecation, assignment, encumbrance, lien (statutory or other) or
preference, priority, right (including, but not limited to, rights of first
offer or first refusal), acquisition options, or other security interest of
any kind or nature whatsoever.



Section 1.04 _Subsidiaries and Predecessor Corporations_. CJC owns 100%
interests in each of (i) JinBaiXing (Shenzhen) Clean Energy Technology Service
Company Limited, (ii) JinTaiHong (Shenzhen) Hotel Management Service Company
Limited (the "Subsidiaries") and these 2 WOFE companies owns 100% in each of
(a) Xiaojin County Jitai Power Investment Company Limited, (b) Xiaojin County
Xin Hong Electric Power Development Company Limited, (c) Xiao Jin County En Ze
Hotel Management Company Limited, and (d) Xiao Jin County SiGuNiang Mountain
Hotel Management Company Limited (the "Subsidiaries"). Except for its
ownership interest in the Subsidiaries, CJC does not have any subsidiaries,
and does not own, beneficially or of record, any shares of any other
corporation, limited liability company or other entity. The corporate
ownership structure is as follows:



![](aiom_101img1.jpg)


 
--- 
\- 2 - 



Section 1.05 _Financial Statements._



| (a)| Included in Schedule 1.05 are (i) the audited balance sheets of CJC as
of December 31, 2015 and the related statements of operations, stockholders'
equity and cash flows for the period ended December 31, 2015 and (i) the
unaudited balance sheets of CJC as of June 30, 2016 and the related statements
of operations, stockholders' equity and cash flows for the period ended June
30, 2016 (together with the notes thereto, collectively, the "Financial
Statements"). 
---|---|--- 

|

|



|

| (b)| The Financial Statements have been prepared in accordance with
generally accepted accounting principles consistently applied throughout the
periods involved. The Financial Statements are true and accurate and present
fairly as of their respective dates the financial condition of CJC. As of the
date of the Financial Statements, except as and to the extent reflected or
reserved against therein, CJC had no liabilities or obligations (absolute or
contingent) which should be reflected in the Financial Statements prepared in
accordance with generally accepted accounting principles, and all assets
reflected therein are properly reported and present fairly the value of the
assets of CJC, in accordance with generally accepted accounting principles.
The statements of operations, stockholders' equity and cash flows reflect
fairly the information required to be set forth therein by generally accepted
accounting principles. 

|

|



|

| (c)| CJC has duly and punctually paid all fees and taxation imposed on CJC
by any nation or government, any state, province, supranational authority or
other political subdivision thereof, any entity exercising executive,
legislative, judicial, regulatory or administration functions of or pertaining
to government, or any government authority, quasi-governmental authority,
agency, department, board, tribunal, commission or instrumentality of Hong
Kong or the United States, any foreign government or supranational authority,
any state of the United States, or any municipality or other political
subdivision thereof, and any court, tribunal or arbitrator(s) of competent
jurisdiction, and any governmental or non-governmental self-regulatory
organization, agency or authority (each, a "Governmental Authority"), which it
has become liable to pay and has duly allowed for all taxation reasonably
foreseeable and is under no liability to pay any penalty or interest in
connection with any claim for fees or taxation imposed by any Governmental
Authority, and CJC has made any and all proper declarations and returns for
taxation purposes and all information contained in such declarations and
returns is true and complete and full provision or reserves have been made in
its financial statements for all fees and taxation imposed by any Governmental
Authority. 

|

|



|

| (d)| The Financial Statements, books and records, financial and otherwise,
of CJC are in all material aspects complete and correct and have been
maintained in accordance with good business and accounting practices. 

|

|



|

| (e)| All of CJC's assets are reflected on the Financial Statements, and,
except as set forth in the schedules referenced in this Article I (the "CJC
Schedules") or the Financial Statements, CJC has no material liabilities,
direct or indirect, matured or unmatured, contingent or otherwise. 



Section 1.06 _Additional Information_. The information concerning CJC set
forth in this Agreement and in the CJC Schedules is complete and accurate in
all material respects and does not contain any untrue statement of a material
fact or omit to state a material fact required to make the statements made, in
light of the circumstances under which they were made, not misleading. In
addition, to the extent not otherwise disclosed in the remainder of the CJC
Schedules, Schedule 1.06 sets forth all additional information relating to
matters involving CJC or its assets or its present or past operations or
activities which (i) indicated or may indicate, in the aggregate, the
existence of a greater than $50,000 liability, (ii) have led or may lead to a
competitive disadvantage on the part of CJC or (iii) either alone or in
aggregation with other information covered by this Section 1.06, otherwise
have led or may lead to a material adverse effect on CJC, its assets, or its
operations or activities as presently conducted or as contemplated to be
conducted after the Closing Date, including, but not limited to, information
relating to governmental, employee, environmental, litigation and securities
matters and transactions with affiliates.


 
--- 
\- 3 - 



Section 1.07 _Options or Warrants_. There are no existing options, warrants,
calls, or commitments of any character relating to the authorized and unissued
stock of CJC.



Section 1.08 _Absence of Certain Changes or Events_. Since June 30, 2016 or
such other date as provided for herein:



| (a)| There has not been any material adverse change in the business,
operations, properties, assets, or condition (financial or otherwise) of CJC; 
---|---|--- 

|

|



|

| (b)| CJC has not (i) amended its Articles of Association; (ii) declared or
made, or agreed to declare or make, any payment of dividends or distributions
of any assets of any kind whatsoever to stockholders or purchased or redeemed,
or agreed to purchase or redeem, any of its shares; (iii) made any material
change in its method of management, operation or accounting, (iv) entered into
any other material transaction other than sales in the ordinary course of its
business; or (v) made any increase in or adoption of any profit sharing,
bonus, deferred compensation, insurance, pension, retirement, or other
employee benefit plan, payment, or arrangement made to, for, or with its
officers, directors, or employees; and 

|

|



|

| (c)| Except as disclosed on Schedule 1.08(c), CJC has not (i) granted or
agreed to grant any options, warrants or other rights for its stocks, bonds or
other corporate securities calling for the issuance thereof, (ii) borrowed or
agreed to borrow any funds or incurred, or become subject to, any material
obligation or liability (absolute or contingent) except as disclosed herein
and except liabilities incurred in the ordinary course of business; (iii) sold
or transferred, or agreed to sell or transfer, any of its assets, properties,
or rights or canceled, or agreed to cancel, any debts or claims; or (iv)
issued, delivered, or agreed to issue or deliver any stock, bonds or other
corporate securities including debentures (whether authorized and unissued or
held as treasury stock) except in connection with this Agreement. 



Section 1.09 _Litigation and Proceedings_. Except as disclosed on Schedule
1.09, there are no actions, suits, proceedings, or investigations pending or,
to the knowledge of CJC after reasonable investigation, threatened, by or
against CJC or affecting CJC or its properties or operations, at law or in
equity, before any court or other governmental agency or instrumentality,
domestic or foreign, or before any arbitrator of any kind. CJC does not have
any knowledge of any material default on its part with respect to any
judgment, order, injunction, decree, award, rule, or regulation of any court,
arbitrator, or governmental agency or instrumentality or of any circumstances
which, after reasonable investigation, would result in the discovery of such a
default.



Section 1.10 _Contracts._



| (a)| All Material Contracts (as defined below) to which CJC is a party or by
which it or any of its assets, products, technology, or properties are bound
other than those incurred in the ordinary course of business are set forth on
Schedule 1.10(a). A "Material Contract" is any contract, agreement, franchise,
license agreement, debt instrument or commitment which (i) will remain in
effect for more than six (6) months after the date of this Agreement or (ii)
involves aggregate obligations (by any party thereto) of at least fifty
thousand U.S. dollars (US$50,000). 
---|---|--- 

|

|



|

| (b)| All Material Contracts to which CJC is a party or by which its
properties are bound are valid and enforceable by CJC in all respects, except
as limited by bankruptcy and insolvency laws and by other laws affecting the
rights of creditors generally; and 

|

|



|

| (c)| Except as included or described in Schedule 1.10(c) or reflected in the
most recent CJC balance sheet, CJC is not a party to any oral or written (i)
contract for the employment of any officer or employee; (ii) profit sharing,
bonus, deferred compensation, stock option, severance pay, pension benefit or
retirement plan, (iii) agreement, contract, or indenture relating to the
borrowing of money, (iv) guaranty of any obligation; (vi) collective
bargaining agreement; or (vii) agreement with any present or former officer or
director of CJC. 

 

--- 
\- 4 - 



Section 1.11 _Compliance With Laws and Regulations._ To the best of its
knowledge, CJC has complied with all applicable statutes and regulations of
all Governmental Authorities, except to the extent that noncompliance would
not materially and adversely affect the business, operations, properties,
assets, or condition of CJC or except to the extent that noncompliance would
not result in the occurrence of any material liability for CJC.



Section 1.12 _CJC Schedules_. The CJC Schedules are complete, true, and
correct as of the date of this Agreement in all material respects. CJC shall
cause the CJC Schedules and the instruments and data delivered to Axiom
hereunder to be promptly updated after the date hereof up to and including the
Closing Date.



Section 1.13 _Valid Obligation_. This Agreement and all agreements and other
documents executed by CJC or the CJC Shareholders in connection herewith
constitute the valid and binding obligations of CJC and the CJC Shareholders,
enforceable against each of them in accordance with its or their terms, except
as may be limited by bankruptcy, insolvency, moratorium or other similar laws
affecting the enforcement of creditors' rights generally and subject to the
qualification that the availability of equitable remedies is subject to the
discretion of the court before which any proceeding therefore may be brought.



Section 1.14 _Investment Representations._



| (a)| _Investment Purpose_. As of the date hereof, each of the CJC
Shareholders understand and agree that the consummation of this transactions
contemplated herein including the delivery of the Exchange Consideration to
the CJC Shareholder in exchange for the CJC Shares as contemplated hereby,
constitutes the offer and sale of securities under the Securities Act of 1933,
as amended (the "Securities Act ") and applicable state statutes and that the
CJC Shares are being acquired for the CJC Shareholders' own accounts and not
with a present view towards the public sale or distribution thereof, except
pursuant to sales registered or exempted from registration under the
Securities Act; provided, however, that by making the representations herein,
the CJC Shareholders do not agree to hold any of the Exchange Consideration
for any minimum or other specific term and reserve the right to dispose of the
Exchange Consideration at any time in accordance with or pursuant to a
registration statement or an exemption under the Securities Act. 
---|---|--- 

|



| 

| (b)| _Accredited Investor Status_. Each CJC Shareholder is an "accredited
investor" as that term is defined in Rule 501(a) of Regulation D (an
"Accredited Investor"). 

|



| 

| (c)| _Reliance on Exemptions_. Each CJC Shareholder understands that the
Exchange Consideration is being offered and sold to the CJC Shareholders in
reliance upon specific exemptions from the registration requirements of United
States federal and state securities laws and that Axiom is relying upon the
truth and accuracy of, and the CJC Shareholders' compliance with, the
representations, warranties, agreements, acknowledgments and understandings of
the CJC Shareholders set forth herein in order to determine the availability
of such exemptions and the eligibility of the CJC Shareholders to acquire the
Exchange Consideration. 

 

--- 
\- 5 - 



| (d)| _Information_. The CJC Shareholders and their respective advisors, if
any, acknowledge and agree that they have been furnished with all materials
relating to the business, finances and operations of Axiom and materials
relating to the offer and sale of the Exchange Consideration which have been
requested by the any CJC Shareholder or its advisors. The CJC Shareholders and
their respective advisors, if any, have been afforded the opportunity to ask
questions of Axiom and have had such questions answered to their satisfaction.
Notwithstanding the foregoing, Axiom has not disclosed to any CJC Shareholder
any material nonpublic information and will not disclose such information
unless such information is disclosed to the public prior to or promptly
following such disclosure to the applicable CJC Shareholder(s). Each CJC
Shareholder understands that its investment in the Exchange Consideration
involves a significant degree of risk. Neither CJC nor any CJC Shareholder is
aware of any facts that may constitute a breach of any of Axiom\'s
representations and warranties made herein. 
---|---|--- 

|



| 

| (e)| _Governmental Review_. Each CJC Shareholder understands that no
Governmental Authority has passed upon or made any recommendation or
endorsement of the Exchange Consideration. 

|



| 

| (f)|

 _Transfer or Re-sale_. Each CJC Shareholder acknowledges and understands that
(i) the sale or re-sale of the Exchange Consideration (as hereinafter defined)
has not been and is not being registered under the Securities Act or any
applicable state securities laws, and the Exchange Consideration may not be
transferred unless (a) the Exchange Consideration is sold pursuant to an
effective registration statement under the Securities Act, (b) the applicable
CJC Shareholder shall have delivered to Axiom, at the cost of the applicable
CJC Shareholder, an opinion of counsel that shall be in form, substance and
scope customary for opinions of counsel in comparable transactions to the
effect that the Exchange Consideration to be sold or transferred may be sold
or transferred pursuant to an exemption from such registration, which opinion
shall be accepted by Axiom, (c) the Exchange Consideration is sold or
transferred to an "affiliate" (as defined in Rule 144 promulgated under the
Securities Act (or a successor rule) ("Rule 144")) of the applicable CJC
Shareholder who agrees to sell or otherwise transfer the Exchange
Consideration only in accordance with this Section and who is an Accredited
Investor, (d) the Exchange Consideration is sold pursuant to Rule 144, or (e)
the Exchange Consideration is sold pursuant to Regulation S under the
Securities Act (or a successor rule) ("Regulation S"), and the applicable CJC
Shareholder shall have delivered to Axiom, at the cost of the applicable CJC
Shareholder, an opinion of counsel that shall be in form, substance and scope
customary for opinions of counsel in corporate transactions, which opinion
shall be accepted by Axiom; (ii) any sale of such Exchange Consideration made
in reliance on Rule 144 may be made only in accordance with the terms of Rule
144 and further, if Rule 144 is not applicable, any re-sale of such Exchange
Consideration under circumstances in which the seller (or the Person through
whom the sale is made) may be deemed to be an underwriter (as that term is
defined in the Securities Act) may require compliance with some other
exemption under the Securities Act or the rules and regulations of the SEC
thereunder; and (iii) neither Axiom nor any other Person is under any
obligation to register such Exchange Consideration under the Securities Act or
any state securities laws or to comply with the terms and conditions of any
exemption thereunder (in each case). Notwithstanding the foregoing or anything
else contained herein to the contrary, the Exchange Consideration may be
pledged as collateral in connection with a bona fide margin account or other
lending arrangement. 

|



| 

| (g)| _Legends_. Each of the CJC Shareholders understands that the shares of
Axiom's common stock that comprise the Exchange Consideration (the "Exchange
Shares") may, until such time as the Exchange Shares have been registered
under the Securities Act, bear a restrictive legend in substantially the
following form (and a stop-transfer order may be placed against transfer of
the certificates for such Exchange Shares): 



|



|


 


|



|

 **"** **NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS
CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE
HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR
APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR
SALE,** **SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE
REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS
AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE
COMPANY), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED
UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE** **14** **4 OR RULE 144A
UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED
IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING
ARRANGEMENT SECURED BY THE SECURITIES. "** 

 ** ** 

--- 
\- 6 - 



The legend set forth above shall be removed and Axiom shall issue a
certificate without such legend to the holder of any Exchange Share upon which
it is stamped, if, unless otherwise required by applicable state securities
laws, (a) the Security Shares are registered for sale under an effective
registration statement filed under the Securities Act or otherwise may be sold
pursuant to Rule 144 or Regulation S without any restriction as to the number
of securities as of a particular date that can then be immediately sold, or
(b) such holder provides Axiom with an opinion of counsel, in form, substance
and scope customary for opinions of counsel in comparable transactions, to the
effect that a public sale or transfer of such Exchange Shares may be made
without registration under the Securities Act, which opinion shall be accepted
by Axiom so that the sale or transfer is effected. Each CJC Shareholder agrees
to sell all Exchange Shares, including those represented by a certificate(s)
from which the legend has been removed, in compliance with applicable
prospectus delivery requirements, if any.



| (h)| _Residency_. Each CJC Shareholder is a resident of the jurisdiction
set forth immediately below the CJC Shareholder's name on the signature pages
hereto. 
---|---|--- 

|



|

|

| (i)| _No "Bad Actor" Disqualification_. CJC has exercised reasonable care,
in accordance with Securities and Exchange Commission rules and guidance, to
determine whether any Covered Person (defined below) is subject to any of the
"bad actor" disqualifications described in Rule 506(d)(1)(i) to (viii) under
the Securities Act ("Disqualification Events"). To CJS' knowledge, no Covered
Person is subject to a Disqualification Event, except for a Disqualification
Event covered by Rule 506(d)(2) or (d)(3) under the Securities Act. CJC has
complied, to the extent applicable, with any disclosure obligations under Rule
506(e) under the Securities Act. "Covered Persons" are those persons specified
in Rule 506(d)(1) under the Securities Act, including CJC; any predecessor or
Affiliate of CJC; any director, executive officer, other officer participating
in the Exchange, general partner or managing member of CJC; any beneficial
owner of 20% or more of CJC's outstanding voting equity securities, calculated
on the basis of voting power; any promoter (as defined in Rule 405 under the
Securities Act) connected with CJC in any capacity at the time of the
Exchange; and any Person that has been or will be paid (directly or
indirectly) remuneration for solicitation of purchasers in connection with the
Exchange (a "Solicitor"), any general partner or managing member of any
Solicitor, and any director, executive officer or other officer participating
in the Exchange of any Solicitor or general partner or managing member of any
Solicitor. 



ARTICLE II.

REPRESENTATIONS, COVENANTS, AND WARRANTIES OF AXIOM



As an inducement to, and to obtain the reliance of CJC and the CJC
Shareholder, except as set forth in the Axiom Schedules (as hereinafter
defined), Axiom represents and warrants, as of the date hereof and as of the
Closing Date, as follows:



Section 2.01 _Organization_. Axiom is a corporation duly organized, validly
existing, and in good standing under the laws of the State of Nevada and has
the corporate power and is duly authorized under all applicable respects as it
is now being conducted. Included in Schedule 2.01 are complete and correct
copies of the certificate of incorporation and bylaws of Axiom as in effect on
the date hereof. The execution and delivery of this Agreement does not, and
the consummation of the transactions contemplated hereby will not, violate any
provision of Axiom's certificate of incorporation or bylaws. Axiom has taken
all action required by law, its certificate of incorporation, its bylaws, or
otherwise to authorize the execution and delivery of this Agreement, and Axiom
has full power, authority, and legal right and has taken all action required
by law, its certificate of incorporation, bylaws, or otherwise to consummate
the transactions herein contemplated.


 
--- 
\- 7 - 



Section 2.02 _Capitalization_. Axiom's authorized capitalization consists of
(a) 3,000,000,000 shares of common stock, par value $0.001 per share ("Axiom
Common Stock"), of which 340,000,000 shares are issued and outstanding, and
(b) 50,000,000 shares of preferred stock, par value $.001 per share, none of
which are issued and outstanding. All issued and outstanding shares are
legally issued, fully paid, and non-assessable and not issued in violation of
the preemptive or other rights of any Person.



Section 2.03 _Subsidiaries and Predecessor Corporations_. Axiom does not have
any predecessor corporation(s), no subsidiaries, and does not own,
beneficially or of record, any shares of any other corporation.



Section 2.04 _Information._ The information concerning Axiom set forth in this
Agreement and the scheduled referenced in this Article II (the "Axiom
Schedules") is complete and accurate in all material respects and does not
contain any untrue statements of a material fact or omit to state a material
fact required to make the statements made, in light of the circumstances under
which they were made, not misleading. In addition, Axiom has fully disclosed
in writing to the CJC Shareholders (through this Agreement or the Axiom
Schedules) all information relating to matters involving Axiom or its assets
or its present or past operations or activities which (i) indicated or may
indicate, in the aggregate, the existence of a greater than $50,000 liability,
(ii) have led or may lead to a competitive disadvantage on the part of Axiom
or (iii) either alone or in aggregation with other information covered by this
Section 2.04, otherwise have led or may lead to a material adverse effect on
Axiom, its assets, or its operations or activities as presently conducted or
as contemplated to be conducted after the Closing Date, including, but not
limited to, information relating to governmental, employee, environmental,
litigation and securities matters and transactions with affiliates.



Section 2.05 _Options or Warrants._ Except as set forth in Schedule 2.05,
there are no options, warrants, convertible securities, subscriptions, stock
appreciation rights, phantom stock plans or stock equivalents or other rights,
agreements, arrangements or commitments (contingent or otherwise) of any
character issued or authorized by Axiom relating to the issued or unissued
capital stock of Axiom (including, without limitation, rights the value of
which is determined with reference to the capital stock or other securities of
Axiom) or obligating Axiom to issue or sell any shares of capital stock of, or
options, warrants, convertible securities, subscriptions or other equity
interests in, Axiom. There are no outstanding contractual obligations of Axiom
to repurchase, redeem or otherwise acquire any shares of Axiom Common Stock of
Axiom or to pay any dividend or make any other distribution in respect thereof
or to provide funds to, or make any investment (in the form of a loan, capital
contribution or otherwise) in, any Person.



Section 2.06 _Absence of Certain Changes or Events._ Since June 30, 2016 or
such other date as provided for herein:



| (a)| There has not been (i) any material adverse change in the business,
operations, properties, assets or condition of Axiom or (ii) any damage,
destruction or loss to Axiom (whether or not covered by insurance) materially
and adversely affecting the business, operations, properties, assets or
condition of Axiom; 
---|---|--- 

|



| 

| (b)| Axiom has not (i) amended its certificate of incorporation or bylaws
except as required by this Agreement; (ii) declared or made, or agreed to
declare or make any payment of dividends or distributions of any assets of any
kind whatsoever to stockholders or purchased or redeemed, or the aggregate are
outside of the ordinary course of business or material considering the
business of Axiom; (iv) made any material change in its method of management,
operation, or accounting; (v) entered into any transactions or agreements
other than in the ordinary course of business; (vi) made any accrual or
arrangement for or payment of bonuses or special compensation of any kind or
any severance or termination pay to any present or former officer or employee;
(vii) increased the rate of compensation payable or to become payable by it to
any of its officers or directors or any of its salaried employees whose
monthly compensation exceed $1,000; or (viii) made any increase in any profit
sharing, bonus, deferred compensation, insurance, pension, retirement, or
other employee benefit plan, payment, or arrangement, made to, for or with its
officers, directors, or employees; 

 

--- 
\- 8 - 



| (c)| Axiom has not (i) granted or agreed to grant any options, warrants, or
other rights for its stock, bonds, or other corporate securities calling for
the issuance thereof; (ii) borrowed or agreed to borrow any funds or incurred,
or become subject to, any material obligation or liability (absolute or
contingent) except liabilities incurred in the ordinary course of business;
(iii) paid or agreed to pay any material obligations or liabilities (absolute
or contingent) other than current liabilities reflected in or shown on the
most recent Axiom balance sheet and current liabilities incurred since that
date in the ordinary course of business and professional and other fees and
expenses in connection with the preparation of this Agreement and the
consummation of the transaction contemplated hereby; (iv) sold or transferred,
or agreed to sell or transfer, any of its assets, properties, or rights
(except assets, properties, or rights not used or useful in its business
which, in the aggregate have a value of less than $1,000), or canceled, or
agreed to cancel, any debts or claims (except debts or claims which in the
aggregate are of a value less than $1,000); (v) made or permitted any
amendment or termination of any contract, agreement, or license to which it is
a party if such amendment or termination is material, considering the business
of Axiom; or (vi) issued, delivered or agreed to issue or deliver, any stock,
bonds or other corporate securities including debentures (whether authorized
and unissued or held as treasury stock), except in connection with this
Agreement; and 
---|---|--- 

|



| 

| (d)| to its knowledge, Axiom has not become subject to any law or regulation
which materially and adversely affects, or in the future, may adversely
affect, the business, operations, properties, assets or condition of Axiom. 



Section 2.07 _Litigation and Proceedings._ Except as set forth on Schedule
2.07, there are no actions, suits, proceedings or investigations pending or,
to the knowledge of Axiom after reasonable investigation, threatened by or
against Axiom or affecting Axiom or its properties, at law or in equity,
before any court or other governmental agency or instrumentality, domestic or
foreign, or before any arbitrator of any kind. Axiom has no knowledge of any
default on its part with respect to any judgment, order, writ, injunction,
decree, award, rule or regulation of any court, arbitrator, or governmental
agency or instrumentality or any circumstance which after reasonable
investigation would result in the discovery of such default.



Section 2.08 _Contracts._



| (a)| Axiom is not a party to, and its assets, products, technology and
properties are not bound by, any leases, contract, franchise, license
agreement, agreement, debt instrument, obligation, arrangement, understanding
or other commitments whether such agreement is in writing or oral
("Contracts"). 
---|---|--- 

|



|

|

| (b)| Axiom is not a party to or bound by, and the properties of Axiom are
not subject to any Contract, agreement, other commitment or instrument; any
charter or other corporate restriction; or any judgment, order, writ,
injunction, decree, or award; and 

|



|

|

| (c)| Axiom is not a party to any oral or written (i) contract for the
employment of any officer or employee; (ii) profit sharing, bonus, deferred
compensation, stock option, severance pay, pension benefit or retirement plan,
(iii) agreement, contract, or indenture relating to the borrowing of money,
(iv) guaranty of any obligation, (vi) collective bargaining agreement; or
(vii) agreement with any present or former officer or director of Axiom. 

 

--- 
\- 9 - 



Section 2.09 _No Conflict With Other Instruments._ The execution of this
Agreement and the consummation of the transactions contemplated by this
Agreement will not result in the breach of any term or provision of,
constitute a default under, or terminate, accelerate or modify the terms of,
any indenture, mortgage, deed of trust, or other material agreement or
instrument to which Axiom is a party or to which any of its assets, properties
or operations are subject.



Section 2.10 _Compliance With Laws and Regulations._ Axiom has complied with
all United States federal, state or local or any applicable foreign statute,
law, rule, regulation, ordinance, code, order, judgment, decree or any other
applicable requirement or rule of law (a "Law") applicable to Axiom and the
operation of its business. This compliance includes, but is not limited to,
the filing of all reports to date with federal and state securities
authorities.



Section 2.11 _Approval of Agreement._ The Board of Directors of Axiom has
authorized the execution and delivery of this Agreement by Axiom and has
approved this Agreement and the transactions contemplated hereby.



Section 2.12 _Material Transactions or Affiliations._ Except as disclosed
herein or in Schedule 2.12, there exists no contract, agreement or arrangement
between Axiom and any predecessor and any Person who was at the time of such
contract, agreement or arrangement an officer, director, or Person owning of
record or known by Axiom to own beneficially, 5% or more of the issued and
outstanding common stock of Axiom and which is to be performed in whole or in
part after the date hereof or was entered into not more than three years prior
to the date hereof. Neither any officer, director, nor 5% Shareholders of
Axiom has, or has had since inception of Axiom, any known interest, direct or
indirect, in any such transaction with Axiom which was material to the
business of Axiom. Axiom has no commitment, whether written or oral, to lend
any funds to, borrow any money from, or enter into any other transaction with,
any such affiliated Person.



Section 2.13 _Axiom Schedules_. Axiom shall cause the Axiom Schedules and the
instruments and data delivered to CJC and the CJC Shareholder hereunder to be
promptly updated after the date hereof up to and including the Closing Date.



Section 2.14 _Bank Accounts; Power of Attorney_. Schedule 2.14 sets forth a
true and complete list of (a) all accounts with banks, money market mutual
funds or securities or other financial institutions maintained by Axiom within
the past twelve (12) months, the account numbers thereof, and all persons
authorized to sign or act on behalf of Axiom, (b) all safe deposit boxes and
other similar custodial arrangements maintained by Axiom within the past
twelve (12) months, (c) the check ledger for the last 12 months, and (d) the
names of all persons holding powers of attorney from Axiom or who are
otherwise authorized to act on behalf of Axiom with respect to any matter,
other than its officers and directors, and a summary of the terms of such
powers or authorizations.



Section 2.15 _Valid Obligation._ This Agreement and all agreements and other
documents executed by Axiom in connection herewith constitute the valid and
binding obligation of Axiom, enforceable in accordance with its or their
terms, except as may be limited by bankruptcy, insolvency, moratorium or other
similar laws affecting the enforcement of creditors' rights generally and
subject to the qualification that the availability of equitable remedies is
subject to the discretion of the court before which any proceeding therefore
may be brought.



Section 2.16 _SEC Filings; Financial Statements_.



| (a)| Axiom has made available on EDGAR, copies of each report, registration
statement and definitive proxy statement filed by Axiom with the SEC since its
initial filing on May 14, 2014 (the "Axiom SEC Reports"). 
---|---|--- 

|



|

|

| (b)| Axiom Common Stock is quoted on the OTC QB tier of the OTC Markets and
is current in its filings. There is no action or proceeding pending or, to
Axiom's knowledge, threatened against Axiom by The Financial Industry
Regulatory Authority, Inc. ("FINRA") with respect to any intention by such
entity to prohibit or terminate the quotation of Axiom Common Stock on the OTC
Pink No Information tier. 

 

--- 
\- 10 - 



ARTICLE III.

SHARE EXCHANGE



Section 3.01 _The Exchange._ On the terms and subject to the conditions set
forth in this Agreement, on the Closing Date, the CJC Shareholder shall sell,
assign, transfer and deliver, free and clear of all liens, pledges,
encumbrances, charges, restrictions or known claims of any kind, nature, or
description, all of the CJC shares held by such CJC Shareholder in exchange
for the issuance to the CJC Shareholders collectively of

200,000,000 shares of Axiom's Common Stock representing approximately 58.8% of
the issued and outstanding shares of Axiom's Common Stock after giving effect
to the cancellation of 200,000,000 shares of Common Stock currently issued and
outstanding. On the Closing Date (as defined below), the CJC Shareholders
shall, on surrender of their certificates representing their respective CJC
Shares to Axiom or its registrar or transfer agent, be entitled to receive a
certificate or certificates evidencing their respective ownership of the
Exchange Consideration. The number of shares of Axiom Common Stock to be
received by each CJC Shareholder is as set forth on Schedule 3.01. Upon
consummation of the transaction contemplated herein, all of the issued and
outstanding CJC Shares shall be held by Axiom. Axiom will use its best efforts
to Raise USD$ 25,000,000 in working capital for CJC.



Section 3.02 _Closing._ The closing of the transactions contemplated by this
Agreement ("Closing") shall occur at a mutually agreeable time and place
within five (5) Business Days (as defined below) following, and subject to,
the satisfaction or waiver by the party for whose benefit such condition
exists of the conditions set forth in Article V and Article VI (the date of
such Closing, the "Closing Date"). A "Business Day" is any day on which banks
are generally open for business in the State of Florida.



Section 3.03 _Closing Events._ At the Closing, Axiom, CJC and the CJC
Shareholders shall execute, acknowledge, and deliver (or shall ensure to be
executed, acknowledged, and delivered), any and all certificates, opinions,
financial statements, schedules, agreements, resolutions, rulings or other
instruments required by this Agreement to be so delivered at or prior to the
Closing, together with such other items as may be reasonably requested by the
parties hereto and their respective legal counsel in order to effectuate or
evidence the transactions contemplated hereby.



Section 3.04 _Termination_.



| (a)| This Agreement may be terminated: 
---|---|--- 



| (i)| by mutual written consent of CJC, each CJC Shareholder and Axiom; 
---|---|--- 

|



|

|

| (ii)| by either CJC or Axiom if there shall be in effect a final
nonappealable order, judgment, injunction or decree entered by or with any
Governmental Authority restraining, enjoining or otherwise prohibiting the
consummation of the transactions contemplated hereby; 

|



|

|

| (iii)| by Axiom if there shall have been a breach in any material respect of
any representation, warranty, covenant or agreement on the part of any CJC
Shareholder or CJC set forth in this Agreement and such breach has not been
cured within ten (10) days after receipt of notice of such breach by CJC and
each applicable CJC Shareholder; 

|



|

|

| (iv)| by CJC if there shall have been a breach in any material respect of
any representation, warranty, covenant or agreement on the part of Axiom set
forth in this Agreement and such breach has not been cured within ten (10)
days after receipt of notice of such breach by Axiom; 

|



|

|

| (v)| by either the CJC or Axiom if the Closing has not occurred by February
15, 2017, provided, however, that if the Closing has not occurred by such date
due to a breach of this Agreement by a party, such party shall not have the
right to terminate this Agreement pursuant to this Section 3.04(a)(v). 

 

--- 
\- 11 - 



| (b)| If this Agreement is terminated pursuant to this Section 3.04, this
Agreement shall be of no further force or effect, and no obligation, right or
liability shall arise hereunder, provided, however, that such termination
shall not excuse any breach or default of this Agreement prior to such
termination. 
---|---|--- 



ARTICLE IV.

SPECIAL COVENANTS



Section 4.01 _Access to Properties and Records._ Following the date hereof and
until the Closing or termination of this Agreement, each of Axiom and CJC will
each afford to the officers and authorized representatives of the other full
access to the properties, books and records of Axiom or CJC, as the case may
be, in order that each may have a full opportunity to make such reasonable
investigation as it shall desire to make of the affairs of the other, and each
will furnish the other with such additional financial and operating data and
other information as to the business and properties of Axiom or CJC, as the
case may be, as the other shall from time to time reasonably request. Without
limiting the foregoing, as soon as practicable after the end of each fiscal
quarter (and in any event through the last fiscal quarter prior to the Closing
Date), each party shall provide the other with quarterly internally prepared
and unaudited financial statements.



Section 4.02 _Delivery of Books and Records._ At the Closing, CJC shall
deliver to Axiom the originals of the corporate minute books, books of
account, contracts, records, and all other books or documents of CJC now in
the possession of CJC or its representatives.



Section 4.03 _Third Party Consents and Certificates._ Axiom and CJC agree to
cooperate with each other in order to obtain any required third party consents
to this Agreement and the transactions herein contemplated.



Section 4.04 _Axiom SEC Filings._ On or after the Closing Date, Axiom shall
file with the SEC necessary disclosure statements required by federal
securities law.



Section 4.05 _Designation of Directors._



| (a)| As of, and dependent on, the Closing, the parties will execute such
documents and undertake such actions as required to cause the Board of
Directors of Axiom following the Closing Date to consist of (i) one current
director of Axiom and (ii) two directors appointed by the CJC Shareholders
(the "New Directors"). 
---|---|--- 

|



|

|

| (b)| In the event that the CJC Shareholders cannot agree on the designation
of the New Directors, CJC shall have the right to designate the New Directors. 



Section 4.06 _Actions Prior to Closing._



| (a)| From and after June 30, 2016 until the Closing Date or the earlier
termination of this Agreement, CJC shall, and the CJC Shareholder will cause
CJC to: 
---|---|--- 



| (i)| conduct its business in the ordinary course in a manner consistent with
past custom and practice; 
---|---|--- 

|



| 

| (ii)| pay all accounts payable, purchase inventory, and collect all accounts
receivable in the ordinary course of business consistent with past custom and
practice; 

 

--- 
\- 12 - 



| (iii)| use reasonable efforts to maintain its business and employees,
customers, assets, and operations as an ongoing business and in accordance
with past custom and practice; 
---|---|--- 

|



| 

| (iv)| not sell, transfer, or otherwise dispose of any of the capital stock
of CJC or subsidiaries or issue capital stock of CJC or any subsidiaries; 

|



| 

| (v)| not pay any dividend, without notifying Axiom, or make any similar
distribution or redeem, purchase, or otherwise acquire, directly or
indirectly, any of CJC's or any of its subsidiaries' capital stock; 

|



| 

| (vi)| not sell, transfer, or otherwise dispose, without notifying Axiom, any
of the tangible or intangible assets of CJC or any subsidiary (other than the
sales of inventory in the normal course of business); 

|



| 

| (vii)| not grant any increase in the compensation or benefits of any
employee or officer of CJC or any subsidiary (other than in the ordinary
course of business in accordance with past practice); and 

|



| 

| (viii)| not enter into any transaction with any affiliate of CJC (including,
without limitations, the CJC Shareholders). 

 

| (b)| From and after June 30, 2016 until the Closing Date or the earlier
termination of this Agreement, neither Axiom nor CJC will, except as provided
for in Section 4.06(e): 
---|---|--- 



| (i)| make any changes in their Articles of Association, articles or
certificate of incorporation or bylaws except as contemplated by this
Agreement including a name change; 
---|---|--- 

|



|

|

| (ii)| take any action described in Section 1.08 in the case of CJC or in
Section 2.06, in the case of Axiom (all except as permitted therein or as
disclosed in the applicable party's schedules); 

|



|

|

| (iii)| enter into or amend any contract, agreement, or other instrument of
any of the types described in such party's schedules, except that a party may
enter into or amend any contract, agreement, or other instrument in the
ordinary course of business involving the sale of goods or services; or 

|



|

|

| (iv)| sell any assets or discontinue any operations, sell any shares of
capital stock or conduct any similar transactions other than in the ordinary
course of business except as disclosed in the Axiom SEC Reports. 



| (c)| From and after June 30, 2016 until the Closing Date or the earlier
termination of this Agreement, the CJC Shareholders shall cause each of the
officers and directors of CJC to do all such further acts as shall be required
to permit Axiom to file any required documents (including 10-Ks, 10-Qs, 8-Ks,
federal and state tax returns, or otherwise) to be filed at or following the
Closing Date which reflect the business and operations of CJC prior to the
Closing Date, and shall execute and deliver all certifications, if any,
required to be filed by Axiom with respect to financial statements of CJC
reflecting in whole or in part the business and operations of CJC prior to the
Closing. 
---|---|--- 

|

|



|

| (d)| Following the date hereof until the Closing Date or the earlier
termination of this Agreement, neither CJC, nor any CJC Shareholder, will
enter into or pursue any arrangements or negotiations with any other party
relative to the disposition of any ownership interest in CJC or its assets, or
the merger or acquisition of CJC with or into any other party. 

|

|



|

| (e)| Axiom shall have entered into an agreement for and have completed the
cancellation of at least 200,000,000 shares of its Common Stock. 

 

--- 
\- 13 - 



Section 4.07 _Indemnification._



| (a)| CJC hereby agrees to indemnify Axiom and each of the officers, agents,
directors and shareholders of Axiom (the "Axiom Indemnitees") against any
loss, expense, liability, claim, damage, costs, judgments, deficiencies,
assessments, actions, investigations, penalties, fines, settlements, interest
and damages (including reasonable attorneys' fees and expenses), and
including, but not limited to, any and all expense whatsoever reasonably
incurred in investigating, preparing, or defending against any litigation,
commenced or threatened, or any claim whatsoever, (collective, "Losses"), to
which it or they may become subject arising out of or based on (i) any false
or inaccurate representation or warranty made by or on behalf of CJC in or
pursuant to this Agreement; (ii) any default or breach by CJC in the
performance of any of the covenants or agreements made by CJC in or pursuant
to this Agreement; (iii) the operation of CJC's business prior to the Closing;
(iv) any breach of contract or agreement of CJC prior to the Closing and (iv)
any claim for any commission or fee by any broker or entity if such claim
arises on account of any act of any CJC or any CJC Shareholder. 
---|---|--- 

|



|

|

| (b)| The CJC Shareholders, jointly and severally, agree to indemnify the
Axiom Indemnitees against any Losses, to which it or they may become subject
arising out of or based on (i) any false or inaccurate representation or
warranty made by or on behalf of any CJC Shareholders in or pursuant to this
Agreement; (ii) any default or breach by any CJC Shareholder in the
performance of any of the covenants or agreements made by any CJC Shareholders
in or pursuant to this Agreement; and (iii) any claim for any commission or
fee by any broker or entity if such claim arises on account of any act of any
CJC Shareholder. The indemnification provided for in this paragraph shall
survive the Closing and consummation of the transactions contemplated hereby
and termination of this Agreement for one year following the Closing. 

|



|

|

| (c)| Axiom hereby agrees to indemnify the CJC Shareholders, CJC and each of
the officers, agents, directors and shareholders of the forgoing (the "CJC
Indemnitees") against any Losses, to which it or they may become subject
arising out of or based on (i) any false or inaccurate representation or
warranty made by or on behalf of Axiom in or pursuant to this Agreement; (ii)
any default or breach by Axiom in the performance of any of the covenants or
agreements made by Axiom in or pursuant to this Agreement; (iii) the operation
of Axiom's business prior to the Closing; (iv) any breach of contract or
agreement of Axiom prior to the Closing and (iv) any claim for any commission
or fee by any broker or entity if such claim arises on account of any act of
Axiom. 

|



|

|

| (d)| The indemnification provided for in this Section 4.07 shall survive the
Closing and consummation of the transactions contemplated hereby and
termination of this Agreement for one year following the Closing. Nothing
contained in this Agreement or otherwise shall limit any action by any party
for fraud or intentional misrepresentation by any other party relating to this
Agreement or any of the transactions contemplated hereby. 



ARTICLE V.

CONDITIONS PRECEDENT TO OBLIGATIONS OF AXIOM



The obligations of Axiom under this Agreement are subject to the satisfaction,
at or before the Closing Date, of the following conditions:



Section 5.01 _Accuracy of Representations and Performance of Covenants._ The
representations and warranties made by CJC and the CJC Shareholders in this
Agreement shall have been true when made and shall be true at the Closing Date
with the same force and effect as if such representations and warranties were
made at and as of the Closing Date (except for changes therein permitted by
this Agreement), in all material respects. CJC and the CJC Shareholders shall
have performed or complied in all material respects with all covenants and
conditions required by this Agreement to be performed or complied with by CJC
or the CJC Shareholder prior to or at the Closing. Axiom shall be furnished
with a certificate, signed by a duly authorized executive officer of CJC and
dated the Closing Date, to the foregoing effect.


 
--- 
\- 14 - 



Section 5.02 _Officer 's Certificate._ Axiom shall have been furnished with a
certificate dated the Closing Date and signed by a duly authorized officer of
CJC to the effect that no litigation, proceeding, investigation, or inquiry is
pending, or to the best knowledge of CJC threatened, which might result in an
action to enjoin or prevent the consummation of the transactions contemplated
by this Agreement, or, to the extent not disclosed in the CJC Schedules, by or
against CJC, which might result in any CJC Material Adverse Effect (as defined
below).



Section 5.03 _No Governmental Prohibition._ No order, statute, rule,
regulation, executive order, injunction, stay, decree, judgment or restraining
order shall have been enacted, entered, promulgated or enforced by
Governmental Authority which prohibits the consummation of the transactions
contemplated hereby.



Section 5.04 _Consents._ All consents, approvals, waivers or amendments
pursuant to all contracts, licenses, permits, trademarks and other intangibles
in connection with the transactions contemplated herein, or for the continued
operation of CJC after the Closing Date on the basis as presently operated
shall have been obtained.



Section 5.05 _Other Items._



| (a)| Axiom and counsel for Axiom shall have completed a review and
evaluation of CJC and its operations and shall be satisfied with the results
thereof in the sole discretion of Axiom, including, without limitation, a
review and evaluation of the including ownership of the following subsidiaries
and assets of CJC's subsidiaries: 
---|---|--- 



| (i)| Xiaojin County Jitai Power Investment Company Limited - holding 3 power
stations; 
---|---|--- 

|



|

|

| (ii)| Xiaojin County Xin Hong Electric Power Development Company Limited -
holding 1 power station which is 25mW; 

|



|

|

| (iii)| Xiao Jin County En Ze Hotel Management Company Limited - holding a
190 room hotel; and 

|



|

|

| (iv)| Xiao Jin County SiGuNiang Mountain Hotel Management Company Limited -
holding 90 rooms. 



| (b)| CJC shall have provided Axiom with CJC financial statements for the
periods ended December 31, 2015 and 2014 with such financial statements
audited by a PCAOB registered accounting firm along with unaudited financial
statements for the period ended June 30, 2016. 
---|---|--- 

|



|

|

| (c)| No CJC Material Adverse Effect shall have occurred. 

|



|

|

| (d)| Axiom shall have received such further opinions, documents,
certificates or instruments relating to the transactions contemplated hereby
as Axiom may reasonably request. 

 

--- 
\- 15 - 



Section 5.06 _Definition._ For purposes herein, "CJC Material Adverse Effect"
shall mean a material adverse effect on the business, results of operations,
financial condition, properties or assets of CJC, all taken as a whole;
provided, however, that "CJC Material Adverse Effect" shall not include the
impact on such business, results of operations, financial condition,
properties or assets to the extent arising out of or attributable to (a)
conditions or effects that generally affect the industries in which CJC
operates (including legal and regulatory changes), (b) effects resulting from
changes in general or any regional, national or international economic,
financial, social or political conditions (including changes therein), (c)
effects resulting from changes in the financial, banking or securities
markets, including changes affecting capital market conditions (including in
each of clauses (a), (b) and (c) above, any effects or conditions resulting
from an outbreak or escalation of hostilities, disease, war, acts of
terrorism, political instability or other national or international calamity,
crisis, emergency, epidemic or natural disaster, act of God or any
governmental or other response to any of the foregoing, in each case whether
or not involving Hong Kong, the United States or any other region where CJC
conducts business or operations), (d) effects resulting from changes in laws
or generally accepted accounting principles ("GAAP"), (e) effects relating to
the announcement of the execution of this Agreement or the transactions
contemplated hereby, (f) effects resulting from compliance with the terms and
conditions of this Agreement by CJC or the CJC Shareholders or actions or
omissions consented to in writing by Axiom, or (g) any matter set forth on the
CJC Schedules; provided, however, that in the case of clauses (a), (b), (c)
and (d), in the event that such events or conditions have a disproportionate
effect on CJC as compared to other entities operating in the industries or
markets in which CJC operates, then such event or condition, solely to the
extent of such disproportionate effect, shall be taken into account in
determining if a CJC Material Adverse Effect has occurred.



ARTICLE VI.

CONDITIONS PRECEDENT TO OBLIGATIONS OF AXIOM



The obligations of CJC and the CJC Shareholders under this Agreement are
subject to the satisfaction, at or before the Closing Date, of the following
conditions:



Section 6.01 _Accuracy of Representations and Performance of Covenants._ The
representations and warranties made by Axiom in this Agreement shall have been
true when made and shall be true as of the Closing Date (except for changes
therein permitted by this Agreement) with the same force and effect as if such
representations and warranties were made at and as of the Closing Date, in all
material respects. Additionally, Axiom shall have performed and complied in
all material respects with all covenants and conditions required by this
Agreement to be performed or complied with by Axiom.



Section 6.02 _Officer 's Certificate._ CJC shall have been furnished with
certificates dated the Closing Date and signed by duly authorized executive
officers of Axiom, to the effect that no litigation, proceeding, investigation
or inquiry is pending, or to the best knowledge of Axiom threatened, which
might result in an action to enjoin or prevent the consummation of the
transactions contemplated by this Agreement or, to the extent not disclosed in
the Axiom Schedules, by or against Axiom, which might result in any Axiom
Material Adverse Effect (as defined below).



Section 6.03 _Good Standing._ CJC shall have received a certificate of good
standing from the Secretary of State of Nevada or other appropriate office,
dated as of a date within ten days prior to the Closing Date certifying that
Axiom is in good standing as a corporation in the State of Nevada and has
filed all tax returns required to have been filed by it to date and has paid
all taxes reported as due thereon.



Section 6.04 _No Governmental Prohibition._ No order, statute, rule,
regulation, executive order, injunction, stay, decree, judgment or restraining
order shall have been enacted, entered, promulgated or enforced by any court
or governmental or regulatory authority or instrumentality which prohibits the
consummation of the transactions contemplated hereby.



Section 6.05 _Axiom Shares._ The number of outstanding shares of Axiom's
Common Stock shall not exceed 340,000,000 and there shall not be any
outstanding any options, warrants, or other securities exercisable or
exchangeable for, or convertible into, shares of Axiom's Common Stock or any
other security of Axiom, other than the CJC Shares. 


 
--- 
\- 16 - 



Section 6.06 _Other Items._



| (a)| Counsel for the CJC Shareholders shall have completed a review and
evaluation of Axiom and its operations and shall be satisfied with the results
thereof in the sole discretion of the CJC Shareholders. 
---|---|--- 

|



|

|

| (b)| No Axiom Material Adverse Effect shall have occurred. 



Section 6.07 _Definition._ For purposes herein, "Axiom Material Adverse
Effect" shall mean a material adverse effect on the business, results of
operations, financial condition, properties or assets of Axiom, all taken as a
whole; provided, however, that "Axiom Material Adverse Effect" shall not
include the impact on such business, results of operations, financial
condition, properties or assets to the extent arising out of or attributable
to (a) conditions or effects that generally affect the industries in which
Axiom operates (including legal and regulatory changes), (b) effects resulting
from changes in general or any regional, national or international economic,
financial, social or political conditions (including changes therein), (c)
effects resulting from changes in the financial, banking or securities
markets, including changes affecting capital market conditions (including in
each of clauses (a), (b) and (c) above, any effects or conditions resulting
from an outbreak or escalation of hostilities, disease, war, acts of
terrorism, political instability or other national or international calamity,
crisis, emergency, epidemic or natural disaster, act of God or any
governmental or other response to any of the foregoing, in each case whether
or not involving Hong Kong, the United States or any other region where Axiom
conducts business or operations), (d) effects resulting from changes in laws
or GAAP, (e) effects relating to the announcement of the execution of this
Agreement or the transactions contemplated hereby, (f) effects resulting from
compliance with the terms and conditions of this Agreement by Axiom or actions
or omissions consented to in writing by CJC or the CJC Shareholders, or (g)
any matter set forth on the Axiom Schedules; provided, however, that in the
case of clauses (a), (b), (c) and (d), in the event that such events or
conditions have a disproportionate effect on Axiom as compared to other
entities operating in the industries or markets in which Axiom operates, then
such event or condition, solely to the extent of such disproportionate effect,
shall be taken into account in determining if an Axiom Material Adverse Effect
has occurred.



ARTICLE VII.

MISCELLANEOUS



Section 7.01 _Brokers._ Axiom and CJC agree that, except as set out on
Schedule 7.01 attached hereto, there were no finders or brokers involved in
bringing the parties together or who were instrumental in the negotiation,
execution or consummation of this Agreement.



Section 7.02 _Governing Law._ This Agreement shall be governed by, enforced,
and construed under and in accordance with the laws of the United States of
America and, with respect to the matters of state law, with the laws of the
State of Florida, in each case without application of the conflicts of laws
provisions thereof. Each of the parties irrevocably consents and agrees that
any legal or equitable action or proceedings arising under or in connection
with this Agreement shall be brought exclusively in United States District
Court for the Middle District of Florida or the state court in Orange County,
Florida. By execution and delivery of this Agreement, each party hereto
irrevocably submits to and accepts, with respect to any such action or
proceeding, generally and unconditionally, the jurisdiction of the aforesaid
courts, and irrevocably waives any and all rights such party may now or
hereafter have to object to such jurisdiction.



Section 7.03 _Waiver of Jury Trial._ EACH PARTY HERETO HEREBY WAIVES, TO THE
FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL
BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR
RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREIN (WHETHER
BASED ON CONTRACT, TORT OR ANY OTHER THEORY). EACH PARTY HERETO (A) CERTIFIES
THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED,
EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF
LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT
AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT
BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS Section
7.03.


 
--- 
\- 17 - 



Section 7.04 _Notices._ Any notice or other communications required or
permitted hereunder shall be in writing and shall be sufficiently given if
personally delivered to it or sent by telecopy, overnight courier or
registered mail or certified mail, postage prepaid, or via email with a read
receipt requested and received, addressed as follows:



If to the CJC Shareholder and CJC, to:



CJC Holdings, Ltd.

Attn. Ms. Nankalamu

Room C, 15/F., Ritz Plaza

122 Austin Road

Tsimshatsui, Kowloon, H.K.



If to Axiom, to: 

Axiom Holdings, Inc.

Attn: Low Tuan Lee

11637 Orpington St. Orlando, FL 32817

With a copy, which shall not constitute notice, to:



Legal and Compliance, LLC

Attn: Laura Anthony, Esq. and Lazarus Rothstein, Esq.

330 Clematis Street, Suite 217

West Palm Beach, FL 33401

Fax: 561-514-0832

Email: _lanthony@legalandcompliance.com_ and lrothstein@legalandcompliance.com



or such other addresses as shall be furnished in writing by any party in the
manner for giving notices hereunder, and any such notice or communication
shall be deemed to have been given (i) upon receipt, if personally delivered,
(ii) on the day after dispatch, if sent by overnight courier, (iii) upon
dispatch, if transmitted by telecopy and receipt is confirmed by telephone or
if sent via email and a read receipt has been requested and received and (iv)
three (3) days after mailing, if sent by registered or certified mail.



Section 7.05 _Attorneys ' Fees._ In the event that any party institutes any
action or suit to enforce this Agreement or to secure relief from any default
hereunder or breach hereof, the prevailing party shall be reimbursed by the
losing party for all costs, including reasonable attorneys' fees, incurred in
connection therewith and in enforcing or collecting any judgment rendered
therein.



Section 7.06 _Confidentiality._ Each party hereto agrees with the other that,
unless and until the transactions contemplated by this Agreement have been
consummated, it and its representatives will hold in strict confidence all
data and information obtained with respect to another party or any subsidiary
thereof from any representative, officer, director or employee, or from any
books or records or from personal inspection, of such other party, and shall
not use such data or information or disclose the same to others, except (i) to
the extent such data or information is published, is a matter of public
knowledge, or is required by law to be published; or (ii) to the extent that
such data or information must be used or disclosed in order to consummate the
transactions contemplated by this Agreement. In the event of the termination
of this Agreement, each party shall return to the applicable other party(ies)
all documents and other materials obtained by it or on its behalf and shall
destroy all copies, digests, work papers, abstracts or other materials
relating thereto, and each party will continue to comply with the
confidentiality provisions set forth herein.


 
--- 
\- 18 - 



Section 7.07 _Public Announcements and Filings._ Unless required by applicable
law or regulatory authority, none of the parties will issue any report,
statement or press release to the general public, to the trade, to the general
trade or trade press, or to any third party (other than its advisors and
representatives in connection with the transactions contemplated hereby) or
file any document, relating to this Agreement and the transactions
contemplated hereby, except as may be mutually agreed by the parties. Copies
of any such filings, public announcements or disclosures, including any
announcements or disclosures mandated by law or regulatory authorities, shall
be delivered to each party at least one (1) business day prior to the release
thereof.



Section 7.08 _Schedules; Knowledge._ Each party is presumed to have full
knowledge of all information set forth in the other party's schedules
delivered pursuant to this Agreement.



Section 7.09 _Third Party Beneficiaries._ This contract is strictly between
Axiom, the CJC Shareholders and CJC, and, except as specifically provided, no
director, officer, stockholder (other than the CJC Shareholders), employee,
agent, independent contractor or any other Person shall be deemed to be a
third party beneficiary of this Agreement.



Section 7.10 _Expenses._ Subject to Section 4.07 and Section 7.05, whether or
not the Exchange is consummated, each of Axiom, CJC and the CJC Shareholders
will bear their own respective expenses, including legal, accounting and
professional fees, incurred in connection with the Exchange or any of the
other transactions contemplated hereby.



Section 7.11 _Entire Agreement._ This Agreement represents the entire
agreement between the parties relating to the subject matter thereof and
supersedes all prior agreements, understandings and negotiations, written or
oral, with respect to such subject matter.



Section 7.12 _Survival; Termination._ The representations, warranties, and
covenants of the respective parties shall survive the Closing Date and the
consummation of the transactions herein contemplated for a period of one year.



Section 7.13 _Counterparts._ This Agreement may be executed in multiple
counterparts, each of which shall be deemed an original and all of which taken
together shall be but a single instrument.



Section 7.14 _Amendment or Waiver._ Every right and remedy provided herein
shall be cumulative with every other right and remedy, whether conferred
herein, at law, or in equity, and may be enforced concurrently herewith, and
no waiver by any party of the performance of any obligation by the other shall
be construed as a waiver of the same or any other default then, theretofore,
or thereafter occurring or existing. At any time prior to the Closing Date,
this Agreement may by amended by a writing signed by all parties hereto, with
respect to any of the terms contained herein, and any term or condition of
this Agreement may be waived or the time for performance may be extended by a
writing signed by the party or parties for whose benefit the provision is
intended.



Section 7.15 _Successors and Assigns._ This Agreement shall inure to the
benefit of and be binding upon the successors and permitted assigns of the
parties hereto. No party may assign any of its rights or obligations under
this Agreement without the written consent of the other parties hereto in
their sole discretion. Any attempted or purported assignment in violation of
this Section 7.15 shall be null and void _ab initio_.



Section 7.16 _Headings and Severability._ The headings in this Agreement are
for convenience of reference only and shall not limit or otherwise affect the
meaning hereof. If any one or more of the provisions contained herein, or the
application thereof in any circumstance, is held invalid, illegal or
unenforceable in any respect for any reason, the validity, legality and
enforceability of any such provision in every other respect and of the
remaining provisions hereof shall not be in any way impaired, unless the
provisions held invalid, illegal or unenforceable shall substantially impair
the benefits of any party of the remaining provisions hereof.


 
--- 
\- 19 - 



Section 7.17 _Interpretation._ The parties acknowledge and agree that (a) each
party reviewed and negotiated the terms and provisions of this Agreement and
has contributed to its revision, and (b) the terms and provisions of this
Agreement shall be construed fairly as to all parties, regardless of which
party was generally responsible for the preparation of this Agreement.
References to a Person also refer to its predecessors and permitted successors
and assigns.



Section 7.18 _Usage._ All pronouns and any variations thereof refer to the
masculine, feminine or neuter, singular or plural, as the context may require.
All terms defined in this Agreement in their singular or plural forms have
corresponding meanings when used herein in their plural or singular forms,
respectively. Unless otherwise expressly provided, the words "include,"
"includes" and "including" do not limit the preceding words or terms and shall
be deemed to be followed by the words "without limitation."



Section 7.19 _Specific Performance._ The parties hereto agree that irreparable
damage would occur in the event that any of the provisions of this Agreement
were not performed by them in accordance with the terms hereof or were
otherwise breached and that each party hereto shall be entitled to an
injunction or injunctions, specific performance and other equitable relief to
prevent breaches of the provisions hereof and to enforce specifically the
terms and provisions hereof, without the proof of actual damages, in addition
to any other remedy to which they are entitled at law or in equity. Each party
agrees to waive any requirement for the security or posting of any bond in
connection with any such equitable remedy, and agrees that it will not oppose
the granting of an injunction, specific performance or other equitable relief
on the basis that (a) the other party has an adequate remedy at law, or (b) an
award of specific performance is not an appropriate remedy for any reason at
law or equity.



Section 7.20 _Commercially Reasonable Efforts._ Subject to the terms and
conditions herein provided, each party shall use its commercially reasonable
efforts to perform or fulfill all conditions and obligations to be performed
or fulfilled by it under this Agreement so that the transactions contemplated
hereby shall be consummated as soon as practicable. Each party also agrees
that it shall use its commercially reasonable efforts to take, or cause to be
taken, all actions and to do, or cause to be done, all things necessary,
proper or advisable under applicable laws and regulations to consummate and
make effective this Agreement and the transactions contemplated herein.



 _[_ _S_ _ignature Pages Follow]_


 

--- 
\- 20 - 



IN WITNESS WHEREOF, the corporate parties hereto have caused this Agreement to
be executed by their respective officers, hereunto duly authorized, as of the
date first-above written.



|

Axiom Holdings, Inc.

| 
---|---|--- 
|

A Nevada corporation

| 
| |

| 
|

By:

| _/s/ Low Tuan Lee_| 
|

|

Low Tuan Lee

| 
|

|

Chief Executive Officer

| 
| |

| 
|

CJC Holdings, Ltd.

| 
|

A Hong Kong company

| 
| |

| 
|

By:

| _/s/ Ms. Nankalamu_| 
|

|

Ms. Nankalamu

| 
|

|

Chief Executive Officer

| 
| | | 
|

CJC Shareholders:

| 
| |

| 
|

By:

| _/s/ Hu Dengyang_| 
|

|

Hu Dengyang

| 

|

|

| 

|

By:

| _/s/ Yang Chuan_| 
|

|

Yang Chuan

| 





\- 21 - 

--- 



   '

